CD8A and neoplasm: It was found that EVs enhanced the systemic delivery of the OVs, resulting in improved tumor-selective delivery, a peritumoral immune response associated with the targeted delivery of the virus, enhanced immunogenicity, and the infiltration of CD4+ and CD8+ T cells [114].